CB Insights
Technology Market Intelligence
Technology Market Intelligence
The Trans-Pacific Technology Fund is a technology-driven venture capital fund, investing in companies that are shaping the future of global business.
Phone: +886 2 2325 8218
12F, No.149, Xinyi Rd
Sec.3, Da-an District
Taipei,
Taiwan
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2020-11-25 | Kata.ai | Series B | MDI Ventures | |
| 2020-09-17 | Finch Therapeutics | Series C | $90M | Avenir Growth Capital, Baupost Group, Humboldt Fund, MSD Capital, MSD Partners, Octave Life Sciences, OCV Partners, OMX Ventures, Shumway Capital, Susquehanna International Group, SymBiosis, and Willett Advisors |
| 2019-05-20 | Finch Therapeutics | Series B - II | $53.47M | Avenir Growth Capital, Morgan Noble Healthcare Partners, OCV Partners, Shumway Capital, Susquehanna International Group, SymBiosis, and Willett Advisors |
| 2018-05-22 | Heal | Series C | $20M | Fidelity Investments, Inflection Capital, IRA Capital, Jim Breyer, Lionel Richie, Paul Jacobs, and RLJ Equity Partners |
| 2017-08-29 | Kata.ai | Series A | $3.5M | Access Ventures, Convergence Ventures, Eddy Chan, MDI Ventures, Red Sails Investment, Telkom Ventures, and VPG Asia |
